中文 | English
Return
Total: 122 , 1/13
Show Home Prev Next End page: GO
Author:(Shu-Yong PENG)

2.Universal strategies and methodologies in broad-spectrum antiviral drug discovery

Shu-jing XU ; Dang DING ; Xin-yong LIU ; Peng ZHAN

Acta Pharmaceutica Sinica 2022;57(5):1289-1300

3.Integrated medicinal chemistry: new modalities and methodologies in drug discovery

Shu-jing XU ; Dang DING ; Xin-yong LIU ; Peng ZHAN

Acta Pharmaceutica Sinica 2022;57(10):2889-2901

4.Research progress of natural products for the treatment of hyperuricemia and gout

Zhi-jiao ZHANG ; Rui-peng LIANG ; Tong ZHAO ; Shu-jing XU ; Xin-yong LIU ; Peng ZHAN

Acta Pharmaceutica Sinica 2022;57(6):1679-1688

6.Analysis on 315 cases of clinical adverse drug reaction/event induced by gastrodin.

Yang-yang ZHENG ; Zhi DONG ; Xiao-qin LU ; Yong-peng XIA ; Shu-bing ZHU

China Journal of Chinese Materia Medica 2015;40(10):2037-2041

7.Fractional and molar esterification rate of high density lipoprotein cholesterol determined by high performance liquid chromatography

Tao PENG ; Jun DONG ; Hongxia LI ; Hanbang GUO ; Yong MAN ; Shu WANG ; Wenxiang CHEN

Chinese Journal of Laboratory Medicine 2008;31(4):415-420

8.Retrospective analysis of epidemiological and clinical features of 86 patients with acute brucellosis

Jian-Wu YU ; Yong-Hua ZHAO ; Peng KANG ; Shu-Chen LI ;

Chinese Journal of Infectious Diseases 1997;0(04):-

9.Analysis of cytogenetic characteristics of 321 children with hypospadias and literature review

Nan LIU ; Guodong XU ; Yong GUAN ; Yue CHEN ; Tong TONG ; Jianbo SHU ; Xiufang ZHI ; Lin PENG

Chinese Journal of Urology 2021;42(3):203-207

10.Bioinorganic chemistry strategies in antiviral drug discovery

Shu-jing XU ; Xu-jie ZHANG ; Dang DING ; Xin-yong LIU ; Peng ZHAN

Acta Pharmaceutica Sinica 2022;57(3):576-592

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 122 , 1/13 Show Home Prev Next End page: GO